4//SEC Filing
Eramian Daniel G 4
Accession 0000891293-12-000040
CIK 0000891293other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 6:54 PM ET
Size
15.2 KB
Accession
0000891293-12-000040
Insider Transaction Report
Form 4
Eramian Daniel G
EVP, Corporate Communications
Transactions
- Award
Common Stock
2012-06-27+27,415→ 1,991,761 total - Sale
Common Stock
2012-06-28$0.57/sh−3,000$1,704→ 1,988,761 total - Sale
Common Stock
2012-06-28$0.58/sh−10,000$5,760→ 1,961,761 total - Sale
Common Stock
2012-06-28$0.57/sh−269$154→ 1,971,761 total - Sale
Common Stock
2012-06-28$0.57/sh−200$114→ 1,988,561 total - Sale
Common Stock
2012-06-28$0.58/sh−20,000$11,600→ 1,941,761 total - Sale
Common Stock
2012-06-28$0.57/sh−6,800$3,876→ 1,981,761 total - Sale
Common Stock
2012-06-28$0.57/sh−9,731$5,556→ 1,972,030 total
Footnotes (1)
- [F1]As disclosed by CTIC in a Form 8-K filed on 12/1/11, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC stock upon the achievement of certain performance goals. The shares reported above on this Form 4 reflect the issuance of vested stock by CTIC pursuant to the award in connection with the achievement of the Pixantrone MAA Approval goal under the award.
Documents
Issuer
CELL THERAPEUTICS INC
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001355850
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 6:54 PM ET
- Size
- 15.2 KB